Modified Growth Releasing Factor aminos 1-29, usually referred to as Modified GRF (1-29) or “ModGRF(1-29),” also known as CJC-1295 without DAC, is a synthetic analog of the endogenous peptide signaling hormone Growth Hormone Releasing Hormone (GHRH). Endogenously produced GHRH has 44 amino acids in its chain structure. A truncated synthetic form of GHRH called Sermorelin or GRF 1-29 has 29 amino acids; Modified GRF (1-29) is further changed in that it has four substituted aminos in its chain that serve the purposes of preventing degradation and oxidation in manufacture and transport as well as in vivo, while also increasing binding affinity to the GHRH receptors.
Related products
Tirzepatide 10mg BUY 1 GET 1 FREE
$259.00(0 Reviews)
Tirzepatide 10mg, a peptide-based medication, has emerged as a groundbreaking treatment in the realm of diabetes care. It belongs to the innovative class of GLP-1 receptor agonists, providing a unique mechanism to combat the multifaceted challenges of type 2 diabetes mellitus (T2DM). Clinical trials have highlighted Tirzepatide's efficacy, indicating its capacity to transform the therapeutic landscape for diabetes.
To take a step towards advanced diabetes management, buy Tirzepatide and explore the cutting-edge treatment that's changing lives by effectively controlling blood sugar levels.
Reviews
There are no reviews yet.